{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:11:11Z","timestamp":1770703871171,"version":"3.49.0"},"reference-count":59,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T00:00:00Z","timestamp":1334880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increased hemodialysis frequency can make fluid overload easier to treat, although most patients are still treated thrice weekly. Chronic fluid overload is associated with left ventricular hypertrophy and elevated serum cardiac biomarkers, recognized as mortality risk factors. Serum cardiac troponin <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">cTnT<\/jats:styled-content>), <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>\u2010terminal prohormone brain natriuretic peptide (<jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\u2010pro<jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content>), left ventricular mass index by cardiac magnetic imaging, and ambulatory blood pressure was measured in 30 thrice weekly hemodiafiltration patients. Time\u2010averaged fluid overload (<jats:styled-content style=\"fixed-case\">TAFO<\/jats:styled-content>) was quantified by bioimpedance spectroscopy. In the study group, left ventricular hypertrophy was found to be 26% by cardiac magnetic resonance. Ambulatory blood pressure was 130\u2009<jats:styled-content style=\"fixed-case\">mmHg<\/jats:styled-content> (112\u2013151) requiring a low equivalent dose of medication of 0.25 units (0\u20131). Significantly, lower levels of left ventricular mass index (<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\u2009&lt;\u20090.05) were associated in those patients with <jats:styled-content style=\"fixed-case\">TAFO<\/jats:styled-content> &lt;1\u2009L or <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\u2010pro<jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content> &lt;1200\u2009pg\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content> or <jats:styled-content style=\"fixed-case\">cTnT<\/jats:styled-content> &lt;0.1\u2009ug\/<jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>. In the subgroups, 16 patients had normal <jats:styled-content style=\"fixed-case\">cTnT<\/jats:styled-content> (&lt;0.03\u2009ug\/<jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>), 16 patients had <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\u2010pro<jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content> &lt;400\u2009pg\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>, and 20 patients had <jats:styled-content style=\"fixed-case\">TAFO<\/jats:styled-content> &lt;1\u2009<jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>. Nine patients had both <jats:styled-content style=\"fixed-case\">cTnT<\/jats:styled-content> &lt;0.03\u2009ug\/<jats:styled-content style=\"fixed-case\">L<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">NT<\/jats:styled-content>\u2010pro<jats:styled-content style=\"fixed-case\">BNP<\/jats:styled-content> &lt;400\u2009pg\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>. Normally hydrated thrice\u2010weekly hemodiafiltration patients can have cardiac biomarker and <jats:styled-content style=\"fixed-case\">TAFO<\/jats:styled-content> levels indistinguishable from the normal healthy population. Obtaining <jats:styled-content style=\"fixed-case\">TAFO<\/jats:styled-content> by bioimpedance monitoring can offer a practical alternative to serum cardiac biomarkers.<\/jats:p>","DOI":"10.1111\/j.1542-4758.2012.00689.x","type":"journal-article","created":{"date-parts":[[2012,4,20]],"date-time":"2012-04-20T08:34:40Z","timestamp":1334910880000},"page":"465-472","source":"Crossref","is-referenced-by-count":20,"title":["Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients"],"prefix":"10.1111","volume":"16","author":[{"given":"Nestor","family":"Velasco","sequence":"first","affiliation":[{"name":"John Stevenson Lynch Renal Unit NHS Ayrshire &amp; Arran  Kilmarnock UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Chamney","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care  Bad Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wabel","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care  Bad Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Moissl","sequence":"additional","affiliation":[{"name":"Fresenius Medical Care  Bad Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toufeeq","family":"Imtiaz","sequence":"additional","affiliation":[{"name":"John Stevenson Lynch Renal Unit NHS Ayrshire &amp; Arran  Kilmarnock UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Spalding","sequence":"additional","affiliation":[{"name":"John Stevenson Lynch Renal Unit NHS Ayrshire &amp; Arran  Kilmarnock UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"McGregor","sequence":"additional","affiliation":[{"name":"John Stevenson Lynch Renal Unit NHS Ayrshire &amp; Arran  Kilmarnock UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Innes","sequence":"additional","affiliation":[{"name":"John Stevenson Lynch Renal Unit NHS Ayrshire &amp; Arran  Kilmarnock UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"MacKay","sequence":"additional","affiliation":[{"name":"John Stevenson Lynch Renal Unit NHS Ayrshire &amp; Arran  Kilmarnock UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajan","family":"Patel","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre University of Glasgow  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Jardine","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre University of Glasgow  Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,4,20]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04571007"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.128157"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP60HTPGIGFCNK"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.08.017"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002087"},{"key":"e_1_2_7_7_1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.V1271508","article-title":"Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients","volume":"12","author":"Zoccali C","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi187"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00477-6"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000041254.30637.34"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.560128"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02395.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01785.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2009.01846.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000157622"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/039139889601900702"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000168968"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp417"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000228541"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm700"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.03.082"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2008.192"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00240107"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000130414"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000286"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.1.80"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn707"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp487"},{"key":"e_1_2_7_29_1","first-page":"587","article-title":"Managing dry weight and hypertension in dialysis patients: Still a challenge for the nephrologist in 2009?","volume":"22","author":"Chazot C","year":"2009","journal-title":"J Nephrol"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000403200112"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.191"},{"key":"e_1_2_7_32_1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1681\/ASN.V115912","article-title":"Serial change in echocardiographic parameters and cardiac failure in end\u2010stage renal disease","volume":"11","author":"Foley RN","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00362.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1159\/000235252"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl487"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2007.00148.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00340705"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00228.x"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001593"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1053\/snep.2001.21672"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2006.01195.x"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.433"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.807362"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1088\/0967-3334\/27\/9\/012"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000167013"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn228"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-097X.2004.00583.x"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03350509"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2009.01090.x"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70007-2"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.3.563"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.26103"},{"issue":"1","key":"e_1_2_7_53_1","first-page":"S73","article-title":"Regression of left ventricular hypertrophy in hemodialysis patients is possible","volume":"58","author":"Hampl H","year":"2002","journal-title":"Clin Nephrol"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.04.030"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.028"},{"key":"e_1_2_7_56_1","first-page":"77","article-title":"Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: A comparative study","volume":"19","author":"Fagugli RM","year":"2006","journal-title":"J Nephrol"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.04.007"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1161\/hy0302.104674"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.071233"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.383"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1542-4758.2012.00689.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1542-4758.2012.00689.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:44:31Z","timestamp":1698626671000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1542-4758.2012.00689.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,20]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1111\/j.1542-4758.2012.00689.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1542-4758.2012.00689.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,20]]}}}